GlassScriptPhysician profile
Nathan Js Almeida
NPI 1669697389
$7,911.83
in general payments reported to CMS, 2019-2025
33 companies · $942 in 2025
The $942 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,823 · 2020: $510 · 2021: $1,098 · 2022: $726 · 2023: $822 · 2024: $992 · 2025: $942.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,755.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,755.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $2,203.81 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $558.96 | 2019-2024 | Farxiga, Wainua |
| Novartis Pharmaceuticals Corporation | $461.52 | 2019-2025 | |
| Boston Scientific Corporation | $454.37 | 2019-2025 | Watchman Flx, Bodyguardian |
| Merck Sharp & Dohme LLC | $434.98 | 2021-2025 | Verquvo |
| Janssen Pharmaceuticals, INC | $406.44 | 2019-2024 | Xarelto |
| Amgen INC. | $396.69 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $377.55 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $371.78 | 2019-2025 | Lifevest |
| Biotronik INC. | $368.03 | 2020-2024 | Biomonitor |
| Abbott Laboratories | $284.14 | 2019-2025 | Perclose Proglide, Amplatzer Amulet, Perclose Prostyle |
| E.R. Squibb & Sons, L.L.C. | $260.29 | 2019-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $218.29 | 2019-2025 | Jardiance |
| Alnylam Pharmaceuticals INC. | $196.68 | 2022-2025 | Onpattro, Amvuttra |
| Novo Nordisk INC | $148.39 | 2024-2025 | Wegovy |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $113.95 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Amarin Pharma, INC. | $106.09 | 2019-2022 | |
| Philips North America LLC | $90.49 | 2023-2024 | (5091) Amb Mon & Diag Und |
| Daiichi Sankyo INC. | $84.51 | 2024-2025 | Injectafer |
| Sanofi-Aventis U.S. LLC | $54.04 | 2019-2024 | |
| Vital Connect, INC | $52.78 | 2024 | Vitalpatch Rtm |
| Kiniksa Pharmaceuticals International, Plc | $39.05 | 2024 | Arcalyst |
| Bayer Healthcare Pharmaceuticals INC. | $37.41 | 2025 | |
| Heartflow, INC. | $26.16 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $25.80 | 2019 | |
| Vifor Pharma, INC. | $22.16 | 2020 | |
| Shockwave Medical, INC | $21.07 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Actelion Pharmaceuticals US, INC. | $20.67 | 2025 | Uptravi, Opsynvi |
| Convatec INC. | $17.71 | 2025 | |
| Edwards Lifesciences Corporation | $17.21 | 2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Inspire Medical Systems, INC. | $14.02 | 2025 | Inspire |
| Kiniksa Pharmaceuticals, LTD. | $13.57 | 2022 | |
| Astellas Pharma US INC | $13.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Almeida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.